Showing results (451-460 of 553) with videos related to

Sort By:
Pageof 56
Drugs in Context|February 5, 2021
Corrigendum: Cost per response analysis of repository corticotropin injection versus other alternative treatments for acute exacerbations of multiple sclerosis
Drugs in Context|November 22, 2018
Repurposing existing drugs for cardiovascular risk management: a focus on methotrexateArduino A Mangoni, Sara Tommasi, Angelo Zinellu, et al.
Drugs in Context|November 8, 2021
Impact of opioid-induced constipation on opioid substitution therapy management: the patient perspectiveFabio Lugoboni, Genevieve Hall, Vivek Banerji
Drugs in Context|August 9, 2019
Palbociclib in metastatic breast cancer: current evidence and real-life dataFrancesco Serra, Pietro Lapidari, Erica Quaquarini, et al.
Drugs in Context|August 9, 2019
Mitochondrial disorders and drugs: what every physician should knowDaniele Orsucci, Elena Caldarazzo Ienco, Gabriele Siciliano, et al.
Drugs in Context|December 31, 2021
The evolution of the overdose epidemic and CDC's research response: a commentaryKristin M Holland, Lara DePadilla, Derrick W Gervin, et al.
Drugs in Context|December 31, 2021
COVID-19-related adaptations to the implementation and evaluation of a clinic-based intervention designed to improve opioid safetyAnna R Morgan, Michelle A Hendricks, Sanae El Ibrahimi, et al.
Drugs in Context|June 2, 2020
Rectal neuroendocrine carcinoma: case report of a rare entity and perspective review of promising agentsGabriela Antelo, Cinta Hierro, Juan Pablo Fernández, et al.
Drugs in Context|August 5, 2021
Real-world impact of switching from tenofovir disoproxil fumarate to tenofovir alafenamideSarah M Michienzi, Mikayla Johnson, Thomas D Chiampas, et al.
Drugs in Context|August 5, 2021
Oscillococcinum® for upper respiratory tract infections and exacerbations in COPD: an observational, prospective study (OXITUNIS)Hichem Aouina, Anis Bamri, Aurélien Vesin, et al.
Pageof 56